IIP is located on 6 acres of land at village Sadavali, about 3 Kms from Devrukh city. The campus includes Administrative area, Instructional Area, Laboratories, Library and Residential buildings etc. in an area admeasuring 5000 Sq.Mtrs. This Institution is a fully developed residential Pharmacy Institute. At present there are over 100 students studying in the Institute.

About Author: Rinki Verma (Research Fellow)
Center of Experimental Medicine and Surgery,
Institute of Medical sciences,
Banaras Hindu University,
Varanasi-221005, India

Abstract
Diabetes mellitus (DM) has reached endemic scope and is an important risk factor for heart failure (HF).Itself indicated as a group of different disease due to destruction of insulin. A large number of therapy available in the management of this but most prominent therapy uses due to their unique properties; stem cell therapy. A stem cell with extensive proliferative nature may provide a precious source of islet progenitor cells. Through transplantation of insulin-producing cells offers a promising therapy to profligate diabetes. A number of studies have demonstrated that a progenitor/stem-cell population can be expanded in vitro to generate large numbers of islet progenitor cells. However, efficient and directed differentiation of these cells to an endocrine pancreatic lineage has been difficult to achieve. They review growing of the islet cells obtained from embryonic stem cell, or adult human tissues which produced insulin to treatments of diabetic patients.

A new study suggests that women with deficiencies of luteinizing hormone (LH) and low dose human chorionic gonadotropin (hCG) can improve the outcome of in vitro fertilization (IVF).

Their vision is to become a leading pharmaceutical company by providing cost effective and high quality treatment and preventive medication to improve the quality of Life. Their company focusses on ensuring Quality and creating value for patients, employees and stakeholders.

Their vision is to become a leading pharmaceutical company by providing cost effective and high quality treatment and preventive medication to improve the quality of Life. Their company focusses on ensuring Quality and creating value for patients, employees and stakeholders.

Banaras Hindu University ranks among the first few in the country in the field of academic and research output. This university has two campuses, 3 institutes, 16 faculties, 140 departments, 4 advanced centers and 4 interdisciplinary schools.

Their vision is to become a leading pharmaceutical company by providing cost effective and high quality treatment and preventive medication to improve the quality of Life. Their company focusses on ensuring Quality and creating value for patients, employees and stakeholders.

The Nagpur University was established on 4th August, 1923 with six affiliated colleges and 927 students. During 1947, the number of students increased to about 9000 accompanied by the improvement and diversification of curricula and expansion in the range of subjects. The expansion of library and sports facilities occurred during these years for the intellectual and physical well being of the students.

AstraZeneca announced top-line results from SATURN. SATURN was designed to measure the impact of CRESTOR (rosuvastatin) 40 mg and atorvastatin 80 mg on the progression of atherosclerosis in high risk patients.

A New studies suggested a new hormonal therapy to reduce risk of venous thromboembolism than oral estrogen-only hormone therapy agents (contraceptive pills). In this study they compared Estradiol transdermal system with oral estrogen hormone therapy.

Tablets India Limited (TIL) is one of the leading manufacturers of various types of Pharmaceutical and nutraceutical formulations. The vital therapeutic range includes nutritional supplements, haematinics, hepatoprotectives, novel antipyretic, a unique G.I. Lavage preparation, Anti-Ulcerant, Osteoporotic Formula, Respiratory Medicine, etc.

Aventis Pharma Limited (part of the Sanofi Group) announced on 24^th August, 2011 that it has entered into a definitive agreement to acquire Universal Medicare Private Limited’s business of marketing and distribution of branded nutraceutical formulations in India. Also, approximately 750 commercial employees will transition to Aventis Pharma Ltd. The transaction has been approved by the Boards of Directors of both companies.

Health biotech is a company that promises good health for all by providing quality medicines at affordable prices and committed to care the people for keeping good health. Health Biotech has won many accolades in the domestic and international pharmaceutical domain.